QCM
TNYA icon

Quantinno Capital Management’s Tenaya Therapeutics TNYA Stock Holding History

Quantinno Capital Management’s Portfolio TNYA Stock Details TNYA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$15.9K Buy
+21,472
New +$16.3K ﹤0.01% 3432

Other funds holding TNYA

Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
EAM
Empery Asset Management New York $86.5M AUM
Marshall Wace
Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return
GCP
GSA Capital Partners London, United Kingdom $1.59B AUM 39.81% 1-Year Est. Return
BGM
Burkehill Global Management New York $2.77B AUM 65.75% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Quantinno Capital Management's TNYA Position: Q2 2026 in Review

Quantinno Capital Management opened a new position in Tenaya Therapeutics (TNYA) in Q2 2026: 21,472 shares worth $15.9K. The stake represents ﹤0.01% of the portfolio and ranks #3432 among its holdings.

101 funds tracked by Wall St. Rank hold TNYA as of Q2 2026.

  • Quantinno Capital Management held 21,472 shares of Tenaya Therapeutics worth $15.9K as of Q2 2026.
  • Tenaya Therapeutics was a new Quantinno Capital Management position in Q2 2026.
  • Tenaya Therapeutics made up ﹤0.01% of Quantinno Capital Management's portfolio in Q2 2026, its #3432 holding.
  • 101 funds tracked by Wall St. Rank held Tenaya Therapeutics as of Q2 2026.

Based on Quantinno Capital Management's 13F filing for Q2 2026, filed 13 Aug 2026.